GE Healthcare and PhotoCure Announce Extension of Bladder Cancer Licensing Partnership to the US Market.CHALFONT ST GILES, England -- GE Healthcare GE Healthcare is a $18 billion (USD) unit of General Electric (GE). It employs more than 46,000 people worldwide and is headquartered in Chalfont St. Giles, Buckinghamshire, United Kingdom. GE Healthcare is the first GE business segment headquartered outside the United States. , a unit of General Electric Company (NYSE NYSE See: New York Stock Exchange :GE) today announced that GE Healthcare has exercised the exclusive option to license PhotoCure's product Hexvix(R) (hexaminolevulinate), an optical molecular imaging agent intended for the diagnosis and monitoring of bladder cancer bladder cancer Malignant tumour of the bladder. The most significant risk factor associated with bladder cancer is smoking. Exposure to chemicals called arylamines, which are used in the leather, rubber, printing, and textiles industries, is another risk factor. , for the US market. This is an extension of the agreement signed earlier this year that afforded GE Healthcare exclusive global rights outside of the Nordic region to market and distribute PhotoCure's product Hexvix. PhotoCure continues to be responsible for manufacturing and Nordic distribution of the product. This license, which is subject to government approval related to competition laws in the US, grants GE the right to market and sell Hexvix in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. pending U.S. Food and Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ) approval of the drug for use. "We believe our partnership with PhotoCure will result in significant patient benefit in the diagnosis and management of bladder cancer," said Daniel L. Peters, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Medical Diagnostics at GE Healthcare. "This partnership underscores GE Healthcare's commitment to addressing the unmet un·met adj. Not satisfied or fulfilled: unmet demands. clinical needs of physician customers and to enhancing the quality of patient care through new approaches to the diagnosis and monitoring of disease." About GE Healthcare GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform and treat disease, so their patients can live their lives to the fullest. GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases Noun 1. neurological disease - a disorder of the nervous system nervous disorder, neurological disorder disorder, upset - a physical condition in which there is a disturbance of normal functioning; "the doctor prescribed some medicine for the disorder"; , and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $15 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 43,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion